The Real Brokerage REAX 深 沪
等待开盘 08-22 09:30:00 美东时间
2.64
-0.110
-4.00%
华盛通- 最 高2.79
- 今 开2.676
- 成交量 743.53万股
- 最 低 2.625
- 昨 收 2.75
- 总市值 57.87万
- 52周最高 5.405
- 市盈率 静 --
- 换手率 3392.00%
- 52周最低 1.55
- 委 比 20.41%
- 总股本 0.00亿
- 历史最高 6.75
- 量 比 1.18
- 振 幅 6.00%
- 历史最低 1.00
- 每 手 1
- 风险率 1.06%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Real and RE/MAX Holdings Securityholders Approve Proposed Combination
Securityholder approval moves Real and RE/MAX Holdings closer to creating Real REMAX Group, a leading technology-enabled global real estate platform built on decades of trust and innovation ...
08-15 04:15
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
Jones Trading Maintains Buy on Real Brokerage, Lowers Price Target to $4
Jones Trading analyst Matthew Erdner maintains Real Brokerage (NASDAQ:REAX) with a Buy and lowers the price target from $5 to $4.
08-07 07:42
Are RMAX, AXTA, CRBG, EQH Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
07-15 04:13
Are CPRX, UNF, RMAX, ACR Obtaining Fair Deals for Their Shareholders?
Insiders may stand to receive substantial financial benefits not available to o...
05-12 14:56
Real Brokerage Q1 EPS $(0.02), Inline, Sales $465.551M Miss $481.872M Estimate
Real Brokerage (TSX:REAX) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $465.551
05-07 19:04
RMAX Legal Alert: RE/MAX Holdings Hit with Investigation Over $13.80 Merger Announcement
NEW YORK, May 5, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into RE/MAX Holdings, Inc.'s (NYSE: RMAX) board of directors as well a...
05-05 18:36
美股大行评级 | 美银大幅上调西部数据、希捷科技目标价！宝洁、Baker Hughes、Flagstar Bank、斯伦贝谢等获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从48美元升至49美元；Chardan Capital：维持Intellia Therapeutics"买入"评级，目标价从27美元升至30美元
04-28 10:07
Are OGN, RMAX, XOMA, REAX Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
04-27 23:24
